Show simple item record

dc.contributor.authorLoi, Barbara
dc.contributor.authorZloh, Mire
dc.contributor.authorAntonietta, Maria
dc.contributor.authorCorkery, John
dc.contributor.authorSchifano, Fabrizio
dc.date.accessioned2017-06-30T13:29:06Z
dc.date.available2017-06-30T13:29:06Z
dc.date.issued2017-06-28
dc.identifier.citationLoi , B , Zloh , M , Antonietta , M , Corkery , J & Schifano , F 2017 , ' 4,4’-dimethylaminorex (‘4,4’-DMAR’; ‘Serotoni’) misuse; a web-based study ' , Human Psychopharmacology: Human and Experimental , vol. 32 , no. 3 , e2575 . https://doi.org/10.1002/hup.2575
dc.identifier.otherPURE: 11146349
dc.identifier.otherPURE UUID: 2f31a5a6-b46e-4739-ad11-66f19cbd76e5
dc.identifier.otherScopus: 85021324487
dc.identifier.urihttp://hdl.handle.net/2299/18697
dc.descriptionThis is the peer reviewed version of the following article: Loi B, Zloh M, De Luca MA, Pintori N, Corkery J, Schifano F. 4,4′-Dimethylaminorex (“4,4′-DMAR”; “Serotoni”) misuse: A Web-based study. Hum Psychopharmacol Clin Exp. 2017;32:e2575, which has been published in final form at https://doi.org/10.1002/hup.2575. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. Copyright © 2017 John Wiley & Sons, Ltd.
dc.description.abstractBackground: 4,4′-DMAR (4,4’-dimethylaminorex; ‘Serotoni’) is a potent stimulant drug which has recently been associated with a number of fatalities in Europe. Over the last few years, online communities have emerged as important resources for disseminating levels of technical knowledge on novel psychoactive substances/NPS. Objective: Analysing the information provided by the fora communities on 4,4’-DMAR use, additionally critical reviewing the available evidence-based literature on this topic. Methods: Different website drug fora were identified. A critical review of the existing evidence-based literature was undertaken. Individuation and analysis of qualitative data from the identified website fora were performed. Results: The combined search results identified six website fora from which a range of qualitative data on recurring themes was collected. These themes included: routes of administration and doses; desired effects; adverse effects; comparison with other drugs; association with other drugs; medications self administered to reverse 4,4’-DMAR action; overall impression; provision of harm reduction advice. Conclusions: Although being characterized by a number of methodological limitations, the social networks’ web monitoring approach (netnography) may be helpful to better understand some of the clinical and psychopharmacological issues pertaining to a range of NPS, including 4,4’-DMAR, for which only extremely little, if any, scientific knowledge is availableen
dc.language.isoeng
dc.relation.ispartofHuman Psychopharmacology: Human and Experimental
dc.rightsEmbargoed
dc.subject4,4′-DMAR
dc.subjectaminorex derivatives
dc.subjectnovel psychoactive substances
dc.subjectonline fora
dc.subjectpsychonauts
dc.subjectstimulants
dc.title4,4’-dimethylaminorex (‘4,4’-DMAR’; ‘Serotoni’) misuse; a web-based studyen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionCentre for Hazard Detection and Protection Research
dc.contributor.institutionMedicinal and Analytical Chemistry
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionCentre for Clinical Practice, Safe Medicines and Drug Misuse Research
dc.description.statusPeer reviewed
dc.date.embargoedUntil2018-05-01
dc.relation.schoolSchool of Life and Medical Sciences
dc.description.versiontypeFinal Accepted Version
dcterms.dateAccepted2017-06-28
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1002/hup.2575
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc/4.0/
rioxxterms.licenseref.startdate2018-05-01
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue
herts.date.embargo2018-05-01
herts.rights.accesstypeEmbargoed


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record